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A 22-year-old male university student was 
referred due to gradual visual loss in his 
left eye since one year ago. His past medical 
and ocular history were unremarkable. On 
ophthalmological examination, best corrected 
visual acuity was 20/20 and 20/80 in the right 
and left eyes respectively. Anterior segment 
examination was unremarkable and intraocular 
pressure was within normal limits in both eyes.
On funduscopic examination of the left 
eye, diffuse parafoveal telangiectatic vessels 
were evident temporal to the fovea. Multiple 
saccular aneurysms surrounded the lesion, but 
no exudation was apparent (Fig. 1).
Fluorescein angiography delineated the 
true extent of the lesion and demonstrated 
some degree of leakage (Figures 2, 3). Retinal 
thickening temporal to the fovea was present 
on optical coherence tomography (OCT) (Fig. 4).
The patient was followed conservatively for 
a while before his vision declined to 20/160. 
Because of the progressive nature of the 
disease and decrease in visual acuity during 
the follow-up period, 1.25 mg bevacizumab 
Figure 3. Fluorescein angiography (late venous phase) 
reveals leakage from the abnormal vessels.
Figure 1.  Fundus  photograph  showing  telangiectatic 
vessels temporal to the macula in the left eye.
Figure 2.  Fluorescein  angiography  (mid-arteriovenous 
phase) demonstrates extensive telangiectatic vessels.Photo Essay; Jabbarpour Bonyadi and Moradian
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was injected intravitreally; two weeks later, 
grid macular photocoagulation was applied to 
the area involved by telangiectasis. One month   
following treatment, vision was improved to 
20/30 and the telangiectatic vessels regressed 
(Fig. 5), macular thickening resolved as 
documented by OCT (Fig. 6) and fluorescein 
angiography showed marked decrease in 
leakage (Figures 7, 8).
Figure 5.  Post-treatment  fundus  photograph  showing 
resolution of abnormal vessels.
Figure 7. Post-treatment fundus fluorescein angiography 
documenting resolution of telangiectatic vessels.
Figure 6.  Post-treatment  OCT  reveals  reduction  in 
macular edema.
Figure 8.  Post-treatment  fluorescein  angiography  (late 
phase) demonstrates marked reduction in leakage.
Figure 4.  OCT  of  the  macula,  note  thickening  and 
hyperreflectivity with neurosensory detachment of the 
temporal macula.Photo Essay; Jabbarpour Bonyadi and Moradian
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DISCuSSION
Juxtafoveal telangiectasis (JFT) represents a 
group of disorders which has been classified 
according to ophthalmoscopic findings and 
natural course. Secondary causes of the 
condition including retinal vein occlusions, 
macroaneurysms, diabetic retinopathy, radiation 
retinopathy, intraocular inflammation, and 
Eales disease1 should be excluded to make 
a diagnosis of idiopathic juxtafoveal retinal 
telangiectasis.
Gass and Blodi1 proposed a classification 
scheme for JFT in 1993. Group 1 patients are 
usually white men with unilateral involvement. 
The area of involvement is located temporal 
to the fovea. The telangiectatic vessels are 
compromised leading to retinal exudates and 
edema. Loss of vision is caused by foveal 
involvement and macular edema, often with 
cystoid changes.1 Laser photocoagulation may 
help prevent accumulation of lipids in the 
fovea.1-4 Group 1 JFT has been suggested to 
be within the spectrum of Coats’ syndrome.
Group 2 JFT consists of bilateral occult 
telangiectasis with minimal exudation associated 
with small subretinal neovascular membranes.1 
These patients are older than those in group 
1 and there is no gender predilection. Visual 
loss results from retinal atrophy rather than 
exudation or retinal edema.1 Diabetes may be an 
underlying cause for group 2 idiopathic JFT.2,3
Treatment of subretinal neovascular 
membranes associated with idiopathic JFT 
using laser photocoagulation5 and surgery6 has 
generally been disappointing, but photodynamic 
therapy may be a useful treatment modality.7
Group 3 patients are usually female. The 
major finding is capillary occlusion with 
enlargement of the foveal avascular zone. 
Theoretically, photocoagulation is not beneficial 
in Group 3.1
Our patient’s visual acuity improved after 
treatment with intravitreal bevacizumab and 
grid macular photocoagulation. As mentioned 
earlier, in group 1 JFT, laser photocoagulation 
prevents the accumulation of lipids in the 
fovea and may stabilize vision, particularly if 
performed prior to accumulation of exudates 
in the fovea.
One important differential diagnosis is 
Leber’s miliary aneurysm which is an idiopathic 
retinal vasculopathy involving one eye of male 
subjects around the fourth decade of life. This 
condition is characterized by dilatation of 
venules and arterioles leading to extravasation 
and deposition of intraretinal exudates localized 
to the temporal retina between the posterior pole 
and the peripheral retina. In contrast to Leber’s 
miliary aneurysms, JFT involves the posterior 
pole causing earlier reduction of vision.8
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